Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105567652A reveals high-purity (R)-HPBE synthesis via novel ketoreductase, offering significant cost reduction and supply chain reliability for ACE inhibitor manufacturing.
Patent CN111057725B reveals enzymatic synthesis for high-purity fungicide intermediates. Discover cost reduction and scalable supply chain solutions for Florylpicoxamid production.
Novel ketoreductase mutant enables high-purity pharmaceutical intermediates manufacturing with substantial cost reduction and enhanced supply chain reliability for global partners.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.